Validation of neutralizing antibody titers for estimating vaccine effectiveness for the Omicron SARS-CoV-2 variant, BA.1
Billy J. Gardner, A. Marm Kilpatrick
doi: https://doi.org/10.1101/2021.12.10.21267594
Billy J. Gardner
1Department of Ecology and Evolutionary Biology, University of California, Santa Cruz, California, USA
A. Marm Kilpatrick
1Department of Ecology and Evolutionary Biology, University of California, Santa Cruz, California, USA
Article usage
Posted August 31, 2023.
Validation of neutralizing antibody titers for estimating vaccine effectiveness for the Omicron SARS-CoV-2 variant, BA.1
Billy J. Gardner, A. Marm Kilpatrick
medRxiv 2021.12.10.21267594; doi: https://doi.org/10.1101/2021.12.10.21267594
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (670)
- Anesthesia (181)
- Cardiovascular Medicine (2654)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12245)
- Forensic Medicine (10)
- Gastroenterology (762)
- Genetic and Genomic Medicine (4113)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2665)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (853)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6538)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)